AW
NVS icon

ACG Wealth’s Novartis NVS Stock Holding History

ACG Wealth’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,246
Closed -$105K – 758
2022
Q2 		$105K Buy
+1,246
New +$109K 0.02% 323
2016
Q4 		– Sell
-4,292
Closed -$304K – 271
2016
Q3 		$304K Buy
4,292
+143
+3% +$10.4K 0.06% 189
2016
Q2 		$307K Buy
4,149
+403
+11% +$27.8K 0.07% 181
2016
Q1 		$243K Sell
3,746
-35
-0.9% -$2.38K 0.05% 193
2015
Q4 		$292K Buy
3,781
+221
+6% +$17.6K 0.07% 170
2015
Q3 		$293K Buy
3,560
+68
+2% +$6.05K 0.08% 159
2015
Q2 		$308K Hold
3,492
– – 0.08% 163
2015
Q1 		$309K Sell
3,492
-753
-18% -$66.8K 0.08% 164
2014
Q4 		$352K Sell
4,245
-58
-1% -$4.81K 0.1% 154
2014
Q3 		$363K Sell
4,303
-567
-12% -$45.9K 0.1% 147
2014
Q2 		$395K Buy
4,870
+1,857
+62% +$146K 0.07% 147
2014
Q1 		$230K Hold
3,013
– – 0.07% 166
2013
Q4 		$217K Buy
+3,013
New +$209K 0.06% 165
2013
Q3 		– Sell
-6,372
Closed -$404K – 129
2013
Q2 		$404K Buy
+6,372
New +$415K 0.16% 103

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

ACG Wealth's NVS Position: Q3 2022 in Review

ACG Wealth sold out of Novartis (NVS) in Q3 2022, closing a stake of 1,246 shares — an estimated $105K sold.

ACG Wealth first reported a position in NVS in Q2 2013 and held it in 14 quarters. The position peaked at $404K in Q2 2013. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.

  • ACG Wealth reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
  • ACG Wealth sold 1,246 Novartis shares in Q3 2022, an estimated $105K.
  • ACG Wealth first reported a position in Novartis in Q2 2013 and held it in 14 quarters.
  • ACG Wealth's Novartis position peaked at $404K in Q2 2013.
  • 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.

Based on ACG Wealth's 13F filing for Q3 2022, filed 3 Nov 2022.